Global Movements | Mary Beth DeLena Joins Clinical-stage Biotechnology Company PepGen as General Counsel and Secretary

BOSTON, Massachusetts, USA: PepGen Inc. (Nasdaq: PEPG), announced the expansion of its executive team with the appointment of Mary Beth DeLena as General Counsel and Secretary on 17 January 2024. 

DeLena joins PepGen with over 20 years of experience advising global life science companies in a broad range of strategic, transactional, and corporate matters with extensive experience in business development, finance, securities, corporate governance, employment and commercial law.

Prior to PepGen, DeLena spent 15 years at Alnylam Pharmaceuticals in roles of increasing responsibility, most recently serving as Senior Vice President, Deputy General Counsel, and Assistant Secretary. During her tenure at Alnylam, Mary Beth advised on multiple transformational strategic collaborations, licensing transactions, and significant capital-raising initiatives. Before joining Alnylam, she was with Praecis Pharmaceuticals, establishing and managing the corporate legal function. 

She started her legal career as an associate in the Boston office of Skadden, Arps, Slate, Meagher & Flom LLP. DeLena received her Juris Doctor from Northeastern University School of Law and her Bachelor of Arts in English from Trinity College.

“We are excited to welcome Mary Beth to the team and look forward to leveraging her extensive legal and compliance experience advising public life science companies,” said James McArthur, Ph.D., President and CEO of PepGen. 

Commenting on her movement DeLena posted on social media platform LinkedIn, "I am excited to join the stellar team at PepGen and look forward to supporting the advancement of potentially transformative treatments to improve the future for patients with devastating neuromuscular and neurological diseases."

Source: GlobeNewswire